drugset
Drugs / Mucl-CART
last change Dec 2020 re-read 2 minutes ago

Mucl-CART

Developed for
acute myeloid leukemia
Investigated by
Nanfang Hospital, Southern Medical University · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · The Third Affiliated Hospital of Southern Medical University · Zhujiang Hospital

Trials 1 · a red edge is where a trial was stopped

today NCT03473457 · not/applicable
201820192020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
— NCT03473457 Apr 2018 → Dec 2020 acute myeloid leukemia Zhujiang Hospital Terminated No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Mucl-CART “one kind of CD38-CART/CD33-CART/CD56-CART/CD123-CART/CD117-CART/CD133-CART/CD34-CART/Mucl-CART therapy in Acute myeloid leukemia(AML)” NCT03473457 ↗